Research has shown that in human breast cancer MCF-7 cells and PC-3 prostate cells, narciclasine can activate Caspase-8 and Caspase-10 receptor pathways and induce apoptosis of tumor cells [27]. This evidence concerns the gene CASP8 and breast carcinoma.